Journal
BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY
Volume 27, Issue 6, Pages 961-972Publisher
ELSEVIER SCI LTD
DOI: 10.1016/j.bpg.2013.08.021
Keywords
Liver cancer; Hepatocellular carcinoma; Surveillance; Cost-effectiveness; Prevention & control; Cost-benefit; Cirrhosis; Screening
Categories
Ask authors/readers for more resources
Screening for primary liver cancer means surveillance for hepatocellular carcinoma (HCC), which is one of the most common cancers worldwide. Detection of HCC for curative treatment is increased by surveillance, but target population, optimal periodicity and cost-effectiveness aspects are still debated issues. The aim of surveillance is to obtain a reduction in HCC-related mortality and this is usually achieved through an early diagnosis that increases both applicability and cost-effectiveness of curative treatments. The aim of the present review is to analyse economic aspects of HCC surveillance. Articles that assessed cost-effectiveness of surveillance for HCC, published between 1996 and February 2013, were reviewed in order to verify the cost-effectiveness of surveillance, its optimal periodicity, the target population and the role of alternative surveillance strategies. International guidelines are currently based on the results of such cost-effectiveness analyses, highlighting the importance of the release of cost-effectiveness-guided guidelines for HCC management. (C) 2013 Elsevier Ltd. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available